Maternal exposure to childhood traumatic events, but not multi-domain psychosocial stressors, predict placental corticotrophin releasing hormone across pregnancy by Steine, Iris et al.
Social Science & Medicine 266 (2020) 113461
Available online 17 October 2020
0277-9536/© 2020 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Maternal exposure to childhood traumatic events, but not multi-domain 
psychosocial stressors, predict placental corticotrophin releasing hormone 
across pregnancy 
Iris M. Steine a,b,*, Kaja Z. LeWinn c, Nadra Lisha d, Frances Tylavsky e, Roger Smith f, 
Maria Bowman f, Sheela Sathyanarayana g,h,i, Catherine J. Karr i, j, Alicia K. Smith k, 
Michael Kobor l, Nicole R. Bush m 
a Visiting Scholar, UC Berkeley, Department of Psychology, 2121 Berkeley Way, Berkeley, CA, 94704, USA 
b Department of Psychosocial Science, University of Bergen, Christiesgate 12, 5015 Bergen, Norway 
c Department of Psychiatry and Weill Institute for Neurosciences, University of California San Francisco, USA 
d Department of General Internal Medicine, University of California San Francisco, USA 
e Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, USA 
f Hunter Medical Research Institute, University of Newcastle, Newcastle, Australia 
g University of Washington Department of Pediatrics, Seattle, USA 
h Seattle Children’s Research Institute, Seattle, USA 
i University of Washington Department of Environmental and Occupational Health Sciences, Seattle, USA 
j University of Washington Departments of Pediatrics, Seattle, USA 
k Department of Gynecology and Obstetrics, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, USA 
l Department of Medical Genetics, University of British Columbia, Canada 
m Departments of Psychiatry and Pediatrics, University of California San Francisco, USA   
A R T I C L E  I N F O   
Keywords: 
Childhood traumatic events 
Maternal psychosocial stress 
Placental corticotrophin releasing hormone 
Stress during pregnancy 
A B S T R A C T   
Maternal psychosocial stress increases the risk of adverse birth and postnatal outcomes for the mother and child, 
but the role of maternal exposure to childhood traumatic events (CTE) and multi-domain psychosocial stressors 
for the level and rise of placental Corticotrophin-Releasing Hormone (pCRH) across pregnancy has been 
understudied. In a sociodemographically and racially diverse sample of 1303 women (64% Black, 36% White/ 
others) with low-medical risk pregnancies at enrollment from Shelby County, Tennessee, USA, blood samples 
were drawn twice, corresponding roughly to second and third trimester, and extracted prior to conducting 
radioimmune assays for pCRH. Mothers reported CTE (physical abuse, sexual abuse, or family violence, in 
childhood), adulthood traumatic events, and interpersonal violence during pregnancy. Neighborhood crime/ 
deprivation was derived using geospatially-linked objective databases. General linear and mixed models tested 
associations between stress exposure variables and pCRH levels and rate of rise, adjusting for obstetric/clinical/ 
health related factors. Maternal CTE did not predict pCRH levels at time 1, but positively predicted levels at time 
2, and the rate of rise in pCRH across pregnancy. Race did not moderate this association. No additional maternal 
stress exposures across adulthood or during pregnancy predicted pCRH outcomes. Findings indicate that 
childhood violence or abuse exposure can become biologically embedded in a manner predicting later prenatal 
physiology relevant for maternal and offspring health, and that such embedding may be specific to childhood, 
but not adulthood, stress. Findings also highlight the placental-fetal unit as a mechanistic pathway through 
which intergenerational transmission of the adverse effects of childhood adversities may occur.   
1. Introduction 
A large empirical literature suggests that maternal exposure to 
psychosocial stress during pregnancy increases the risk of multiple 
adverse birth-related outcomes as well as maternal psychiatric and child 
developmental outcomes, including spontaneous abortions, preterm 
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birth, low birth weight, postpartum depression, infant growth retarda-
tion, postnatal health, augmented stress reactivity, and, in older chil-
dren, reduced cognitive abilities and behavioral- and socioemotional 
problems (Bergman et al., 2007; Buffa et al., 2018; Class et al., 2011; 
Davis et al., 2011; Entringer et al., 2009; Hobel et al., 2008; Loomans 
et al., 2012; Madigan et al., 2018; Qobadi et al., 2016; M. Robinson 
et al., 2008). While such associations have been found across a wide 
range of psychosocial stressor types, the biological pathways linking 
prenatal maternal stress to these outcomes are only starting to become 
illuminated. 
Since the placenta mediates communication between mother and 
fetus (Griffiths and Campbell, 2014; Gude et al., 2004), the 
stress-responsive fetal-placental Corticotrophin-releasing hormone 
(CRH) system has been proposed as a mechanistic pathway for these 
associations (Moog et al., 2016; Sandman, 2018). CRH is a neuropeptide 
that plays a key role in regulating the activity of the 
hypothalamus-pituitary-adrenal (HPA) axis, the major neuroendocrine 
stress response system. While typically barely detectable in human 
plasma, CRH is synthesized and secreted by the placenta during preg-
nancy (pCRH), with maternal levels rising progressively from around 20 
weeks gestation and exponentially increasing during the last 5–6 
gestational weeks, before rapidly returning to pre-pregnancy levels 
postpartum (Campbell et al., 1987; Perkins et al., 1995). Although in-
creases in pCRH levels are normal during pregnancy, comparatively 
higher levels and rate of increase have been linked to adverse perinatal 
outcomes, including maternal preeclampsia, pregnancy-induced hy-
pertension (Harville et al., 2009; Laatikainen et al., 1991) and preterm 
birth (Lee, 2014; Wadhwa et al., 2004), as well as fetal growth restric-
tion (Wadhwa et al., 2004) and physical and muscular maturation 
(Ellman et al., 2008). Moreover, higher pCRH levels have been linked to 
greater risk of maternal psychiatric outcomes, including postpartum 
depression (Glynn and Sandman, 2014; Yim et al., 2009), and to early 
life risk phenotypes and related psychiatric outcomes within her chil-
dren, including higher levels of fear and distress (Davis et al., 2005), 
structural alterations of the brain, externalizing behaviors (Sandman 
et al., 2018), and depression and anxiety symptoms (Howland et al., 
2016), the latter of which have been found to predict psychiatric out-
comes, symptom trajectories, and academic functioning later in life 
(Ialongo et al., 2001). A more comprehensive understanding of envi-
ronmental factors contributing to pCRH level and rate of rise, especially 
potentially modifiable risk factors, is needed. 
A growing number of studies have examined the association between 
psychosocial stress and pCRH level and rise. While some reported posi-
tive associations of pCRH with stressors in the form of perceived stress 
(Hobel et al., 1999) and perceived inadequacy of income (Latendresse 
and Ruiz, 2010), others have reported negative (Harville et al., 2009) or 
no associations (Kramer et al., 2009; Petraglia et al., 2001) with a wide 
range of stressors including perceived stress, job strain, daily hassles and 
interpersonal violence. Others have reported mixed findings, including 
positive associations of pCRH levels with only pregnancy-specific, but 
not general measures of stress (Mancuso et al., 2004), and positive as-
sociations between intimate partner violence, discrimination, neigh-
borhood violence and pCRH levels among Black women only, but not 
among White women (Tse et al., 2012). Differences across studies in 
terms of stressor type, pCRH protocols, and sample characteristics may 
partially explain mixed findings. However, the failure of previous 
studies to include stressors experienced during childhood—the devel-
opmentally sensitive time period during which exposure to severe 
stressors produce pervasive effects on brain development, neuroendo-
crine stress response systems, behavior, and health (Agorastos et al., 
2019; Carr et al., 2020; Lupien et al., 2009; McEwen, 2003; Pechtel and 
Pizzagalli, 2011)—may also play a role. Childhood traumatic events 
(CTE) such as childhood physical-, sexual- or emotional abuse, 
emotional neglect, and family dysfunction, have been linked to 
abnormal stress physiology and HPA-axis functioning in both pregnant 
(Buss et al., 2016; Thomas et al., 2018) and non-pregnant women (Heim 
et al., 2000); to gestational diabetes, preeclampsia, shorter gestational 
length, and postpartum depression in pregnant women (Leigh and Mil-
grom, 2008; Roberts et al., 2013; M. V. Smith et al., 2016); and to 
developmental disorders, birth weight, brain anatomy and stress phys-
iology in offspring (Moog et al., 2018; Roberts et al., 2013). Moreover, 
maternal exposure to traumatic or adverse events in childhood are 
well-established risk factors for traumatic life events in adulthood, 
pregnancy conditions, and health behaviors that have been linked to, or 
may be linked to, higher pCRH levels, including interpersonal violence 
(Ports et al., 2016), gestational diabetes, preeclampsia (Roberts et al., 
2013), obesity (Danese and Tan, 2013), smoking during pregnancy 
(Hughes et al., 2017), socioeconomic status (Fergusson et al., 2013), and 
preterm birth (Leeners et al., 2010). Yet, only two previous studies have 
examined associations between maternal CTE and pCRH levels during 
pregnancy. 
Moog et al. (2016), in a racially diverse sample of 295 women, found 
no association between CTE (physical/emotional/sexual abuse, phys-
ical/emotional neglect) and pCRH levels in early pregnancy, but women 
with CTE showed greater pCRH rise across gestation compared to 
women without CTE. The pCRH increase was approximately double for 
one or more CTE compared to none, with differences emerging around 
19 weeks gestation (Moog et al., 2016). This study, however, did not 
examine other lifetime or current stressor domains. In contrast, Y. Chen 
et al. (2010) found no association between maternal CTE (physical and 
sexual abuse) and pCRH levels in a racially diverse sample of 1216 
women (Y. Chen et al., 2010); however pCRH was measured at a single, 
second trimester time point, precluding the potential to detect associa-
tions arising later in pregnancy or the increase over gestation. In fact, the 
majority of previous maternal stress studies have included only a single 
measure of pCRH (Kramer et al., 2009; Latendresse and Ruiz, 2010; Tse 
et al., 2012) and focused only on a single stressor domain (Moog et al., 
2016; Ramos et al., 2019). Of the few studies examining multiple 
stressor domains, all measured pCRH at a single (often second trimester) 
time point (Kramer et al., 2009; Latendresse and Ruiz, 2010; Tse et al., 
2012). Moreover, most previous studies were conducted in small sam-
ples (e.g. < 200) (Hobel et al., 1999; Latendresse and Ruiz, 2010; Tse 
et al., 2012) or samples with limited sociodemographic diversity (Har-
ville et al., 2009; Latendresse and Ruiz, 2010), with few examining the 
role of sociodemographic (Harville et al., 2009) and neighbo-
rhood/community stressors (Tse et al., 2012), limiting the generaliz-
ability to socioeconomically and racially diverse populations. The latter 
is particularly relevant given racial/ethnic differences in birth-related 
outcomes and stress exposure during pregnancy, particularly higher 
rates of preterm birth (Orchard and Price, 2017; Schaaf et al., 2013) and 
chronic stress during pregnancy (Borders et al., 2015) among Black 
women. Furthermore, several studies have reported lower levels of 
pCRH among Black women compared to White women (Y. Chen et al., 
2010; Glynn et al., 2007; Harville et al., 2009), while other studies did 
not find such differences by race (Borders et al., 2015; Mancuso et al., 
2004). These findings raise the question of whether race may be a factor 
affecting the association between stress exposures and pCRH levels. In 
sum, comprehensive examination of the role of multiple domains of 
stress exposures across the life course for pCRH levels is needed, 
particularly predicting measurements of both the second and third 
trimester pCRH, and from large, sociodemographically diverse samples. 
Based on the above, the aims of this study were threefold: 1) To 
conceptually replicate the previously reported association between CTE 
and pCRH levels and rate of rise (Moog et al., 2016) by examining 
whether such association could be detected in a larger sample, specif-
ically a sociodemographically diverse sample of 1303 pregnant Black 
and White women, adjusting for some of the same obstetric, clinical, and 
health related factors known to be associated with pCRH levels, as well 
as additional potential confounders not included in their model (spe-
cifically, maternal age, maternal education level, marital status, fetal 
sex, gestational week, and maternal social support); 2) To leverage our 
diverse sample to test whether associations between CTE and pCRH 
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would vary by race; 3) To examine the role of multiple other, formerly 
understudied, domains of maternal psychosocial stressors across the life 
course, specifically maternal traumatic life events in adulthood, inter-
personal violence victimization during pregnancy, and neighborhood 
crime and deprivation during pregnancy. Based on literature demon-
strating biological embedding of early life adversity (Bublitz and Stroud, 
2012; Buss et al., 2016; Heim et al., 2000; Thomas et al., 2018) and 
previous studies examining associations between CTE and pCRH levels 
(Y. Chen et al., 2010; Moog et al., 2016), we hypothesized that CTE 
would predict pCRH levels measured during later stages of pregnancy (i. 
e., during the 3rd pregnancy trimester) as well as the rate of rise of pCRH 
during pregnancy (Moog et al., 2016), but not pCRH levels measured 
during earlier stages of pregnancy (i.e., during the 2nd pregnancy 
trimester) (Y. Chen et al., 2010). Based on previous prenatal stress 
exposure studies (Harville et al., 2009), we also hypothesized that 
interpersonal violence victimization during pregnancy would predict 
pCRH levels and rate of rise during pregnancy. Due to a lack of previous 
pCRH studies examining neighborhood factors or lifetime exposure to 
traumatic events, no hypotheses were made for those exposures. 
2. Methods and materials 
2.1. Participants 
The data used in this study came from participants in the University 
of Tennessee Health Science Center’s Conditions Affecting Neuro-
cognitive Development and Learning in Early Childhood (CANDLE) 
study (for a comprehensive methodological overview and baseline 
sample description, see Sontag-Padilla et al., 2015). From December 
2006–July 2011, 1503 women with low-medical risk pregnancies were 
recruited from prenatal clinics with intent to deliver at one of the five 
participating health care settings in Shelby County, Tennessee, USA. 
Inclusion and exclusion criteria are detailed in Supplemental Material. 
Of the initial study sample, pCRH data was available for a subsample of 
1303 women. 
2.2. Procedures 
Participants were recruited between 16 and 29 weeks gestation, and 
were assessed again between 22 and 39 weeks gestation, which pre-
dominantly corresponded to 2nd and 3rd pregnancy trimester (Son-
tag-Padilla et al., 2015). The study was approved by the Institutional 
Review Board at the University of Tennessee Health Science Center. 
Written informed consent was obtained from all participants. Analyses 
were conducted as part of the CANDLE DOHaD study and the ECHO 
PATHWAYS Consortium. 
2.3. Measures 
2.3.1. Placental CRH 
pCRH was measured via blood samples collected using lavender top 
(EDTA) plasma separator tubes obtained at two study visit time points 
during pregnancy. After blood collection, tubes were centrifuged, pro-
cessed, and frozen at − 80. Plasma pCRH assays were completed by Dr. 
Roger Smith’s laboratory at the University of Newcastle, Australia. The 
pCRH concentrations (pg/mL) were analyzed by radioimmunoassay as 
previously described (R. Smith et al., 2009). Extraction recovery was 
87%. Inter- and intra-assay coefficients of variance were 8.7% and 7.3%, 
respectively, which compares favorably with previous studies using this 
methodology, providing superior sensitivity to other approaches. Data 
reduction for the radioimmunoassay was performed with a 
computer-assisted logistics program. Analyses were conducted with 
log-transformed scores to prevent violations of model assumptions for 
ordinary least squares regression. Raw data are presented in nanomoles 
Table 1 
Descriptive Statistics of Sample and Main Variables used in the Study.   
Total Sample (N = 1322) Whites (n = 475) Blacks (n = 847) *p<.05 
Continuous Variables Mean SD Range Mean SD Range Mean SD Range  
Maternal age at recruitment 26.19 5.46 16–40 28.64 4.94 16–39 24.83 5.25 16–40 * 
Gestational age, time 1 assessment (weeks) 23.07 3.07 16.0–29.6 23.01 3.13 16.1–29.6 23.10 3.02 16.0–28.4 ns 
Gestational age, time 2 assessment (weeks) 31.74 1.83 22.4–39.2 31.91 1.59 25.6–39.2 31.64 1.94 22.4–39.2 * 
Income/education composite score 0.03 0.92 − 0.9–2.5 0.70 0.91 − 0.9–2.5 − 0.35 0.69 − 0.9–1.9 * 
Parity 2.56 1.63 1–12 2.25 1.34 1–10 2.74 1.74 1–12 * 
Pre-pregnancy Body Mass Index (BMI) 27.56 7.50 14.2–72.4 25.73 5.98 14.2–50.8 28.59 8.06 14.2–72.4 * 
Brief Symptom Inventory depression t-score 48.27 7.67 36–74 48.07 7.52 36–74 48.39 7.77 36–74 ns 
Social support summary score 3.58 1.87 0–9 4.39 1.91 0–9 3.13 1.69 0–9 * 
Maternal childhood traumatic events 0.52 0.78 0–3 0.42 0.73 0–3 0.58 0.80 0–3 * 
Maternal traumatic life events in adulthood 3.16 2.33 0–14 3.04 2.30 0–14 3.23 2.34 0–12 ns 
Interpersonal violence victimization 0.99 0.89 0–4 0.82 0.69 0–4 1.08 0.97 0–4 * 
Neighborhood crime and deprivation − 0.03 0.96 − 2.1–1.7 − 0.83 0.72 − 2.1–1.4 0.41 0.78 − 2.1–1.7 * 
pCRH level, time 1 58.53 74.91 1.1–1443.0 73.55 75.87 4.3–788.9 50.21 73.14 1.1–1443.0 * 
pCRH level, time 2 364.39 425.63 4.5–6385.0 451.41 424.73 18.2–3515.0 316.30 418.87 4.5–6385.0 * 
pCRH rate of rise from time 1 to time 2 305.86 392.72 3.4–6276.0 377.87 386.65 13.5–3304.0 266.09 390.86 3.4–6276.0 * 
Gestational age (at birth) 38.95 1.34 31.5–42.0 38.96 1.43 28.5–42.0 38.65 2.10 22.4–41.6 * 
Birth weight (grams) 3277.8 498.1 1227.0–4954.0 3420.7 525.3 930.0–4954.0 3128.4 561.2 200.0–4685 * 
Categorical Variables N (%)  N (%)  N (%)   
Marital status 
Married/living together with partner 764 (57.7%)  427 (89.9%)  337 (39.8%)  * 
Single/widowed/divorced/separated/never 
married 
560 (35.3%)  48 (10.1%)  510 (60.2%)   
Gestational diabetes          ns 
Yes 75 (5.7%)  33 (6.9%)  42 (5.0%)   
No 1235 (94.3%)  442 (93.1%)  791 (95.0%)   
Gestational hypertension or preeclampsia          ns 
Yes 124 (9.5%)  38 (8.0%)  85 (10.2%)   
No 1185 (90.5%)  436 (92.0%)  748 (89.8%)   
Tobacco use during pregnancy 
Yes 176 (13.3%)  66 (13.9%)  109 (12.9%)  ns 
No 1148 (86.7%)  409 (86.1%)  738 (87.1%)   
Note: *p < .05 column indicates differences between Whites and Blacks. Ns = Non-statistically significant. 
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per liter (nmol/L) in Table 1. 
2.4. Maternal stress exposures 
Childhood Traumatic Events (CTE). Exposure to CTE was 
measured during the second trimester using the three items from the 
Traumatic Life Events Questionnaire (TLEQ) (Kubany et al., 2000), 
assessing whether women were subjected to 1) physical abuse or 2) 
witnessing family violence “while growing up” or 3) sexual abuse 
“before age thirteen”. A count of the number of potentially traumatic 
childhood adversities experienced was created (range 0–3) (Slopen 
et al., 2018). 
Traumatic Life Events in Adulthood. Maternal exposure to trau-
matic events in adulthood was assessed using 17 items from the TLEQ 
pertaining to adulthood (Kubany et al., 2000; Slopen et al., 2018). A 
count of the number of potentially traumatic events experienced (e.g., 
warfare, serious accidents, natural disaster, sudden death of a loved one) 
was created (range 0–17). 
Interpersonal Violence Victimization during Pregnancy. 
Maternal exposure to physical, sexual or emotional abuse and/or injury 
during pregnancy was measured during the second trimester using the 
short form of the Conflict Tactics Scale (CTS) (Straus and Douglas, 
2004), which measures the extent to which romantic partners engage in 
physical and psychological attacks on each other. Here, four dichoto-
mous items assessing maternal victimization (yes/no) from phys-
ical/sexual/emotional abuse and injury were summed to calculate a 
victimization score (range 0–4). 
Neighborhood Crime and Deprivation. To assess potential stress 
exposure from neighborhood adversities, a composite variable 
comprising geospatially-linked objectively-measured information about 
neighborhood violent crime (derived from the Neighborhood Scout Vi-
olent Crime Index) (Goldman-Mellor et al., 2016), and neighborhood 
quality (derived from the Childhood Opportunity Index (COI), a 
geocode-linked database of a nationally-validated index that compares 
social and economic risks and opportunities relative to nearby neigh-
borhoods) (Acevedo-Garcia et al., 2014). A detailed description of these 
measures and the creation of this composite variable is provided in 
Supplementary Material. 
Inter-correlations between the four stress exposure variables were 
small to moderate, ranging from 0.05 to 0.40. Multiple maternal ob-
stetric/clinical/health related factors were included as covariates, based 
on the existing literature. An overview of all covariates is provided in 
Table 2, and a description of their sources are provided in Supplemen-
tary Material. 
2.5. Statistical analyses 
SAS 9.4 was used to conduct all analyses (SAS, 2008). Descriptive 
analyses for continuous and categorical variables for the overall sample 
and by race were conducted using PROC MEANS and PROC FREQ. 
General linear models, using PROC GLM, were fitted to the data for the 
analyses looking at level (time 1 and time 2 pCRH). For the models 
examining change in pCRH, we used a mixed model (PROC MIXED) with 
a random intercept. Models were run in three steps: 1) the three primary 
models including CTE and all covariates, 2) adding an interaction term 
for CTE with race, and 3) adding the three additional stress exposure 
variables, each in their own model. Models predicting pCRH levels (at 
time 1 and time 2) were adjusted for gestational weeks at the time of the 
collection. In the mixed models, we examined the interaction between 
stress exposure (e.g., CTE) and continuous gestational weeks (timing) to 
understand the effect of CTE exposure on pCRH rate of rise across 
pregnancy. 
Table 2 
Maternal Childhood Traumatic Events and Covariate Variables predicting pCRH Levels and Rate of Rise across Pregnancy.   
GLM pCRH level, time 1 GLM pCRH level, time 2 Mixed Model pCRH rise from time 1 to time 2 
β SE t-value P β SE t-value p β SE t-value p 
Maternal childhood traumatic events (CTE) (CTE) .04 .02 1.45  .06 .03 2.10 * -.07 .05 − 1.32  
Maternal CTE x Gestational Weeks - – –  – – –  .00 .00 2.38 * 
Gestational weeks (time 1) .17 .01 29.69 *** – – –  – – –  
Gestational weeks (time 2) - – – – .23 .01 20.81 *** – – –  
Repeated measures gestational weeks T1-2 - – – – – – – – .21 .00 125.32 *** 
Maternal age .01 .01 2.01 * .00 .00 1.74  .01 .01 2.01 * 
Married/cohabiting 1 -.00 .04 -.03  -.01 .05 -.18  -.00 .05 -.05  
White 2 .41 .05 8.48 *** .33 .05 6.20 *** .38 .05 7.69 *** 
Parity -.03 .01 − 2.33 * -.04 .02 − 2.80 * -.04 .01 − 2.89 * 
Socioeconomic status .01 .03 .20  .02 .04 .67  .02 .03 .52  
Smoking during pregnancy3 -.06 .06 -1.06  -.00 .06 -.06  -.04 .06 -.69  
Pre-pregnancy BMI -.02 .00 6.75 *** -.02 .00 − 5.47 *** -.02 .00 − 6.32 *** 
BSI depression score .00 .00 .23  -.00 .00 -.57  -.00 .00 -.29  
Gestational diabetes 4 .08 .08 1.07  .27 .09 3.00 ** .17 .08 2.18 * 
Gestational hypertension/preeclampsia 5 .22 .06 3.48 *** .45 .07 6.47 *** .34 .06 5.44 *** 
Fetal sex 6 -.00 .04 -.12  -.03 .04 -.71  -.02 .03 -.58  
Maternal social support .01 .01 .62  .00 .01 .21  .00 .01 .40  
Note: Level 1 and Level 2 models used GLM regression. Rise/change model used a mixed model approach, and the effect of CTE on rise is interpreted from the 
interaction coefficient. 1 ‘Single/widowed/divorced/separated/never married’ used as reference group. 2 ‘Black’ used as reference group. 3 ‘No smoking’ used as 
reference group. 4 ‘No gestational diabetes’ used as reference group. 5 ‘No gestational hypertension/preeclampsia’ used as reference group. 6 ‘Female’ used as reference 
group. β = Standardized regression coefficients. SE= Standard errors for standardized regression coefficient. *p < .05, **p < .01, ***p < .001. 
Fig. 1. Plot of log-transformed pCRH by gestational age.  
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3. Results 
Fig. 1 shows log-transformed pCRH levels as a function of gestational 
age. Descriptive statistics for all main study variables, including raw 
pCRH levels, are displayed in Table 1, by total sample and by race given 
limited existing reference data on longitudinal pCRH in diverse samples. 
Notably, pCRH levels and rise were lower for Black women. 
3.1. Maternal CTE 
Results of primary regression analyses and mixed models are dis-
played in Table 2. Adjusting for all covariates, maternal CTE did not 
predict pCRH levels at time 1 (β = 0.04, p = .15), but did predict pCRH 
levels at time 2 (β = 0.06, p = .04). In the mixed models testing the 
association between CTE and repeated measure of pCRH over time, the 
interaction term between CTE and gestational weeks (time) was signif-
icant, showing a positive association with the magnitude of the rise in 
pCRH between participants’ two time points of assessment (β = 0.005, p 
= .02). The significant covariance parameter estimate (0.37, p < .001) 
indicated considerable between-participant variation in the starting 
value, with the calculated intraclass coefficient (ICC = σ2subjectσ2subject+σ2error) 
indicating that 77% of the variability in pCRH is accounted for by the 
participant. Examination of the simple slopes for each level of CTE 
endorsement indicated a slight increase in rise for each additional 
traumatic event (β ACES = 0 = 0.2055, p =<.001, β ACES = 1 = 0.2099, 
p =<.001, β ACES = 2 = 0.2143, p =<.001, β ACES = 3 = 0.2188, p 
=<.001). 
Although not the focus of this study, the covariates that most strongly 
predicted pCRH across pregnancy were being White, gestational dia-
betes, and gestational hypertension/preeclampsia (see Table 2). 
Effect modification by race. No statistically significant interaction 
effects were found between CTE and race in predicting pCRH levels or 
rise (results not shown). 
3.2. Additional multilevel and exposure period stressors 
Adjusting for all covariates and CTE, maternal traumatic life events 
in adulthood (p’s = 0.38 – 0.87), interpersonal violence victimization 
during pregnancy (p’s = 0.39 - 0.46), or neighborhood crime and 
deprivation (p’s = 0.22 – 0.96), did not significantly associate with 
pCRH levels or rate of rise (nonsignificant interaction term in mixed 
model) in the models (results not shown). 
4. Discussion 
In a large, racially and sociodemographically diverse sample of 
women, the present study examined the association of maternal CTE 
with the level and rate of rise of pCRH during pregnancy, whether such 
association varied by race, and whether the consideration of traumatic 
events in adulthood, interpersonal violence, or neighborhood risk dur-
ing pregnancy, would provide additional predictive value. As hypothe-
sized, even after rigorous confounder adjustment, CTE predicted pCRH 
level in later pregnancy and rate of rise across pregnancy. No other 
stressors tested added to the prediction of pCRH. 
Maternal CTE, in the form of exposure to sexual or physical abuse or 
family violence during childhood, did not predict levels of pCRH at time 
1 (largely corresponding to the 2nd trimester), which is consistent with 
Chen and colleagues’ (Y. Chen et al., 2010) finding of no association 
between CTE and pCRH levels measured between 15 and 27 weeks 
gestation. CTE did predict pCRH levels at time 2 (predominantly during 
the 3rd trimester), with an effect corresponding to a 5.5% increase in 
pCRH levels for each additional CTE. This timing-specific finding in-
dicates that differences in pCRH levels as a function of CTE emerge 
during later stages of pregnancy. CTE also predicted a greater rate of 
pCRH rise between assessments, although the increase was small. The 
pattern of associations found here for level and rise are consistent with 
those of Moog and colleagues (Moog et al., 2016) and were detected 
after controlling for the same obstetric, clinical, and health related po-
tential confounders shown to be associated with both CTE and pCRH 
levels, and additional variables not included in their model (maternal 
age, maternal education level, marital status, fetal sex, gestational week, 
and maternal social support). Further, although CTE increases the risk 
for gestational diabetes and preeclampsia (Roberts et al., 2013), smok-
ing during pregnancy (Roberts et al., 2013), prenatal depression (Wosu 
et al., 2015), and lower education levels (Fergusson et al., 2013)—all 
factors associated with pCRH levels (Y. Chen et al., 2010; Ellman et al., 
2008; Holzman et al., 2001; Justus et al., 2004; Kramer et al., 2010; 
Laatikainen et al., 1991; Mancuso et al., 2004; Sandman et al., 2006)— 
CTE remained significant despite inclusion of these variables as cova-
riates in the present study. This increases confidence in the association 
found and suggests CTE-effects are not fully mediated by those health 
behaviors and problems in adulthood. Our findings also expand upon 
previous work (Moog et al., 2016) by showing that inclusion of addi-
tional lifetime and pregnancy period psychosocial stressors did not add 
predictive value, even within a large sample with broad exposure across 
those domains. Taken together, these findings highlight the potency of 
exposure to adverse events early in life in predisposing the individual to 
persistent, measurable changes in the pCRH-system. Subsequently, this 
implicates the placental-fetal pCRH-system as a biologically plausible 
mechanism linking CTE to adverse pregnancy-related, maternal psy-
chiatric, and child developmental outcomes. 
The overall study findings suggest that childhood exposure to trau-
matic events may affect female development in a manner that relates to 
their later life pregnancy levels of pCRH - one of the most salient signals 
shaping human fetal development (Sandman, 2018). Higher pCRH 
levels have potentially profound consequences for both the mother and 
the child, as established by studies linking higher pCRH levels to 
biomedical risks such as preeclampsia and pregnancy-induced hyper-
tension (Harville et al., 2009; Laatikainen et al., 1991), adverse preg-
nancy outcomes such as fetal growth restriction and pre-term birth (Lee, 
2014; Wadhwa et al., 2004), psychiatric health in mothers including 
postpartum depression (Glynn and Sandman, 2014; Yim et al., 2009), 
and to early life development and phenotypes of psychiatric outcomes in 
the child, including infant fear and distress (Davis et al., 2005), cortical 
thinning, externalizing behaviors (Sandman et al., 2018), and depres-
sion and anxiety symptoms (Howland et al., 2016). Of note, post hoc 
analyses showed that both pCRH levels at time 2 and the rate of rise in 
pCRH were correlated with gestational weeks at birth (Pearson’s r =
0.50 and 0.52, for time 2 level and rate of rise, respectively, p < .0001) 
and birth weight (Pearson’s r = − 0.08 and − 0.07, for time 2 level and 
rate of rise, respectively, p < .05) in the present sample, confirming 
relevance for such outcomes in this sample. Building on the collective 
evidence from other studies, our findings here point to the possibility 
that maternal childhood trauma exposure may affect her pregnancy, 
birth outcomes, and postpartum mental health, as well as her child’s 
development and mental health across its lifecourse, via influence on 
pCRH levels. The apparent transdiagnostic and intergenerational im-
plications of pCRH associations with childhood trauma exposure suggest 
further study in this area may be of high public health value. 
While our study does not provide information about how CTE lead to 
higher pCRH levels, several non-mutually exclusive mechanistic path-
ways are plausible. For example, CTE might affect pCRH via influences 
on brain development and life-long patterns of emotionality and stress 
responsivity. Specifically, exposure to CTE or other childhood adver-
sities are linked to structural and functional alterations of brain areas 
and neuroendocrine systems involved in stress response regulation, 
cognition, and emotion (McEwen, 2007), including hyper-reactivity of 
the amygdala (Hein and Monk, 2017; Malter Cohen et al., 2013), a brain 
area crucially involved in threat detection, fear arousal and condition-
ing, and HPA-axis reactivity and regulation (Pruessner et al., 2010; 
Roozendaal et al., 2009). CTE-related HPA-axis hyperactivity has been 
I.M. Steine et al.                                                                                                                                                                                                                                
Social Science & Medicine 266 (2020) 113461
6
shown in both pregnant (Bublitz and Stroud, 2012; Buss et al., 2016; 
Thomas et al., 2018) and non-pregnant women (Heim et al., 2000) and 
may result, in part, from impaired glucocorticoid-induced negative 
feedback inhibition of hypothalamic CRH-secretion due to altered 
glucocorticoid receptor functioning (Frodl and O’Keane, 2013; Ladd 
et al., 2004), possibly caused by epigenetic modifications of the gluco-
corticoid receptor gene (McGowan et al., 2009; Palma-Gudiel et al., 
2015). Veritably, animal experimental studies have linked exposure to 
stressful events early in life to increased basal levels of CRH in the brain 
(Coplan et al., 1996, 2001), and to increased CRH gene expression and 
lower methylation of the CRH gene promoter (J. Chen et al., 2012; A. 
Wang et al., 2014), demonstrating that early life stress can persistently 
alter CRH gene expression and overall levels. In humans, exposure to 
CTE or a broader range of childhood adversities strongly predict 
developing PTSD and depression (Hughes et al., 2017), both of which 
have been linked to higher CRH levels in the brain (Bremner et al., 1997; 
Nemeroff et al., 1984). Thus, CTE-induced neurobiological alterations 
associated with the function of key stress response systems within 
women’s bodies could affect the stress-responsive fetal-placental CRH 
system, and- via the glucocorticoid-induced positive feedback mecha-
nism characterizing this particular system (B. G. Robinson et al., 1988; 
Sirianni et al., 2005)- contribute to higher pCRH levels among 
CTE-exposed women. 
Childhood adversity might also influence pCRH levels via early life 
programming of immune phenotypes (Carroll et al., 2011). CTE and a 
broader range of childhood adversities have been linked to elevated 
inflammation levels in both cross-sectional population studies (Lin et al., 
2016) and longitudinal studies of youth- (Slopen et al., 2013) and adults 
(Baumeister et al., 2016). Pro-inflammatory markers, in turn, have been 
shown to stimulate expression of CRH in both the placenta (Uh et al., 
2008) and in human endometrial cell cultures (Makrigiannakis et al., 
1999), and reversely, CRH has pro-inflammatory effects on the intra-
uterine environment (You et al., 2014). Pro-inflammatory markers have 
also been shown to suppress the expression of 11-hydroxysteroid de-
hydrogenase type 2 (HSD11B2) (Kossintseva et al., 2006), a placental 
barrier enzyme that buffers the impact of maternal glucocorticoid 
exposure, and suppression of which may result in high fetal exposure to 
maternal cortisol (Christiaens et al., 2008; Kossintseva et al., 2006). 
Thus, early life programming of immune phenotypes could be another 
developmental mediator translating CTE into biological risk, via their 
downstream effects on maternal prenatal stress physiology and gesta-
tional biology. 
Race did not moderate the association between CTE and pCRH. 
White women exhibited higher levels and rise of pCRH, relative to Black 
women, consistent with previous reports (Y. Chen et al., 2010; Harville 
et al., 2009; Holzman et al., 2001). Yet, given evidence that Black 
women experience more stress during pregnancy (Borders et al., 2015), 
and the positive correlation between stress and pCRH (Hobel et al., 
1999; Latendresse and Ruiz, 2010; B. G. Robinson et al., 1988), the di-
rection of this difference appears incongruent. One potential explana-
tion could be racial differences in chronic stress, which has been linked to 
lower pCRH levels (Guendelman et al., 2008), and is more prevalent 
among Black women (Borders et al., 2015). Another possible explana-
tion comes from biomedical studies implicating a potential role of the 
placental barrier enzyme HSD11B2 in ancestry-specific differences in 
pCRH levels. Maternal distress has been shown to suppress placental 
HSD11B2 in animal experimental studies (Jensen Peña et al., 2012; 
Mairesse et al., 2007) and in pregnant women (O’Donnell et al., 2012; 
Seth et al., 2015), although only for White women (Capron et al., 2018), 
which potentially could translate to racial differences in downstream 
effects on the cortisol-responsive pCRH system. Finally, there may be 
cultural differences in the exposure to and appraisal of stressors (Brown 
et al., 2020), making counts of exposure types less predictive than re-
ports of distress. Future studies in diverse populations are warranted in 
order to understand the role of racial differences in pCRH and maternal 
and child health disparities. 
Interpersonal violence victimization, neighborhood adversity, and 
traumatic events in adulthood, did not add to the prediction of pCRH in 
the present study. Given that CTE-exposure increases the risk of inter-
personal violence victimization, adulthood traumatic events, and lower 
socioeconomic status (Fergusson et al., 2013), these variables were po-
tential mediators in the association between CTE and pCRH levels, 
making their effects difficult to untangle in models adjusting for CTE. 
However, the low correlation of CTE with these variables in the present 
sample makes this explanation unlikely. Taken together with the finding 
that only CTE predicted pCRH levels and rise, a parsimonious inter-
pretation of the overall study findings is that the timing of exposure to 
stressful events is a key determining factor of whether maternal stress 
becomes biologically embedded in her prenatal stress physiology, with 
childhood events being particularly potent. Such interpretation is in line 
with a large empirical literature demonstrating biological embedding of 
childhood adversities specifically (Berens et al., 2017; Danese and 
Lewis, 2017; Heim et al., 2019; Miller et al., 2011), but should be further 
tested. 
Although not the focus of this study, the large, diverse cohort pro-
vides important information about maternal factors relevant for pCRH 
levels and rise. Alongside race, gestational diabetes and hypertension 
were the strongest predictors of pCRH levels at time 2 and the magni-
tude of pCRH rise across pregnancy. These findings are consistent with 
previous studies linking preeclampsia and pregnancy-induced hyper-
tension to higher pCRH levels (Emanuel et al., 1994; Harville et al., 
2009; Laatikainen et al., 1991), but to our knowledge provide the first 
evidence of an association with gestational diabetes. In this Urban South 
sample with many overweight women, BMI was inversely associated 
with pCRH. Increased BMI has been associated with defective uterine 
contraction at delivery and post-dates delivery (McLean et al., 1995), 
and low pCRH has also previously been associated with post-dates de-
livery (McLean et al., 1995). 
4.1. Clinical and policy implications 
A massive empirical literature has established CTE and a broader 
range of childhood adversities as a major public health concern and root 
cause underlying an extensive range of psychosocial and somatic health 
problems (Hughes et al., 2017), mortality (Bellis et al., 2015), socio-
economic- (Fergusson et al., 2013; Pinto Pereira et al., 2017), birth 
related- (Leigh and Milgrom, 2008; Roberts et al., 2013; M. V. Smith 
et al., 2016), and offspring developmental outcomes (Moog et al., 2018; 
Roberts et al., 2013), and immense societal costs (Bellis et al., 2017; C. T. 
Wang and Holton, 2007). The present study indicates, advancing pre-
vious evidence (Moog et al., 2016), that effects of maternal CTE may 
extend intergenerationally to offspring via shifts in the gestational 
environment related to higher circulating pCRH. Given the large liter-
ature linking higher pCRH levels to biomedical risks (Emanuel et al., 
1994; Laatikainen et al., 1991), adverse pregnancy outcomes (Wadhwa 
et al., 2004), psychiatric health in mothers (Yim et al., 2009), and to 
early life development and phenotypes of psychiatric outcomes in the 
child (Davis et al., 2005; Howland et al., 2016; Sandman et al., 2018), 
this work calls for primary prevention to reduce the occurrence of CTE 
and secondary prevention to disrupt adverse developmental trajectories 
and the intergenerational transmission of their effects. This work also 
points to windows of opportunity to interrupt negative developmental 
trajectories and prevent intergenerational cascades of childhood 
adversity (Borja et al., 2019), which can include universal screening for 
childhood adversities among pregnant women, specifically. The major-
ity of women are comfortable with childhood adversity screenings 
during pregnancy and with discussing screening results with their doc-
tors (Flanagan et al., 2018). Consequently, physicians should routinely 
inquire about physical/sexual/psychological abuse as a part of their 
patients’ medical history; consider such exposures as possible factors in 
the presentation of medical complaints; and collectively provide lead-
ership in raising awareness about the need for such assessments 
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(American Medical Association). Critical in this path is development of 
reliable referral networks to and provision of psychiatric treatment, 
where indicated (Finkelhor, 2018). Though findings should be repli-
cated using broader measures of childhood adversity, the predictive 
value of even simple screening tools is suggested by the present study, 
where the association of CTE with pCRH levels was detected using a 
simple, three-item CTE-screening tool. 
4.2. Study strengths and limitations 
Key strengths of the present study include the large, racially diverse 
sample, the control for multiple obstetric, clinical, and health related 
factors in the statistical analyses, and the examination of a wide range of 
stress exposures. Additional strengths include the thorough, state of the 
art assay of the pCRH samples ensuring precise, reliable CRH values. 
Limitations include having only two time points of pCRH with which to 
estimate rise over pregnancy. Moreover, there were some cases of 
overlap in the assessment time windows. Although sensitivity analyses 
showed that removal of these cases did not change the pattern of asso-
ciation between CTE and pCRH (data not shown), future studies should 
consider including more assessment time points to enable more complex 
statistical modeling that may capture nuances in the temporality of 
pCRH levels over time. The recall of CTE items was limited to three 
domains of traumatic events, and a richer assessment across a broader 
range of exposures would be informative. Specifically, the three CTE- 
items used in the present study all captured exposure to sexual or 
physical violence, which may be classified as a threatening, whereas no 
items on our measure captured deprivation adversity (McLaughlin et al., 
2014; Sheridan and McLaughlin, 2014). Given studies indicating that 
experiences of threat and deprivation may differentially influence neu-
rodevelopment and psychobiology (Lambert et al., 2017; Machlin et al., 
2019; McLaughlin et al., 2019), it is possible that a broader measure that 
also captured deprivation adversity (such as the CDC ACEs 10-item 
scale) may have produced different results. Future studies using a 
broader measure capturing of both threat- and deprivation CTE will be 
informative in terms of ascertaining whether the associations found here 
are specific to violence/abuse exposure in childhood, or adversity more 
broadly. Furthermore, although measures of perceived stress have 
shown low correlations with exposure to stressful life events (Bush et al., 
2017) and stress biomarkers (see for example Harville et al., 2009), the 
present study did not include assessment of psychological distress, and 
such measures may have provided additional information of value in 
these models, thus future studies should consider their inclusion. 
Finally, although enrolling only women with low-medical risk preg-
nancies improved retention and limited fetal loss for the cohort, and still 
resulted in a sample broadly representative of the county it was drawn 
from, analyses within this cohort are not fully representative of all types 
of pregnancies, and effects of CTE may be most pronounced in women 
who were excluded at enrollment due to health conditions. 
5. Conclusions 
The present study found an association between experiencing trau-
matic events in childhood, specifically physical or sexual abuse or do-
mestic violence, and higher levels and rise of pCRH across pregnancy in 
a large, sociodemographically and racially diverse sample of women, 
after adjusting for multiple obstetric, clinical, and health related factors 
associated with pCRH levels. Taken together with the extant literature, 
the findings implicate the placental-fetal unit as a mechanistic pathway 
through which intergenerational transmission of the adverse effects of 
childhood trauma may take place, and add to the growing literature 
calling for systematic efforts to prevent childhood trauma and its 
adverse effects. 
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